Table 3.
Distribution of relevant factors in female patients according to clinical stage
|
Female | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| |
|
Stage I versus II-IV |
Stage I-II versus III-IV |
Stage I-III versus IV |
||||||
| |
|
Stage I |
|
Stage I-II |
|
Stage I-III |
|
|||
| N | % | P-value | N | % | P-value | N | % | P-value | ||
| Age |
|
|
|
0.2566 |
|
|
0.4916 |
|
|
0.4026 |
| |
20-44 |
6 |
54.55 |
|
6 |
54.55 |
|
8 |
72.73 |
|
| |
45-64 |
10 |
31.25 |
|
11 |
34.38 |
|
16 |
50.00 |
|
| |
> = 65 |
8 |
27.59 |
|
11 |
37.93 |
|
15 |
51.72 |
|
| Site |
|
|
|
0.0015 |
|
|
<.0001 |
|
|
0.0005 |
| |
Lip |
2 |
50.00 |
|
3 |
75.00 |
|
3 |
75.00 |
|
| |
Tongue |
16 |
59.26 |
|
19 |
70.37 |
|
23 |
85.19 |
|
| |
Gingiva |
1 |
12.50 |
|
1 |
12.50 |
|
2 |
25.00 |
|
| |
Floor of mouth |
2 |
50.00 |
|
2 |
50.00 |
|
2 |
50.00 |
|
| |
Others |
3 |
10.34 |
|
3 |
10.34 |
|
9 |
31.03 |
|
| Treatment |
|
|
|
|
|
|
|
|
|
|
| |
S |
17 |
60.71 |
|
20 |
71.43 |
|
24 |
85.71 |
|
| |
RT |
0 |
0.00 |
|
0 |
0.00 |
|
0 |
0.00 |
|
| |
CT |
0 |
0.00 |
|
0 |
0.00 |
|
3 |
15.79 |
|
| |
S + RT |
4 |
57.14 |
|
4 |
57.14 |
|
6 |
85.71 |
|
| |
S + CT |
2 |
18.18 |
|
3 |
27.27 |
|
5 |
45.45 |
|
| |
RT + CT |
1 |
25.00 |
|
1 |
25.00 |
|
1 |
25.00 |
|
| S + RT + CT | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | ||||
S: surgery; R: radiation; C: chemotherapy.